4-tert-Butylsulfonylcalix[4]arene>98.0%(HPLC)5g

11-Chloro-7,8,9,10-tetrahydro-6H-cyclohepta[b]quinoline, 95+%, 1g

1-(4-Amino-3-bromophenyl)ethanone, 95.0%, 5g

2,2'-OXYBIS(N,N-DIETHYLETHANAMINE), 95.0%, 1g

[1-(1H-benzimidazol-2-yl)-1-methylethyl]amine dihydrochloride, 95.0%, 250mg

6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide (Lornoxicam), 97.0%, 1g

(R)-1-(naphthalen-1-yl)-N-(3-(trifluoromethyl)benzyl)ethanamine hydrochloride, 98%, 100mg

Ethyl 2-oxocyclooctane-1-carboxylate, 95+%, 5g

Methyl 2-phenylbutanoate, 95.0%, 250mg

Tappi di chiusura, Gesch. anteriore, Ø 13 mm 1000 pz

2,6-Dichloropyrimidine-4,5-diamine, 95%, 100mg

tert-Butyl trans-4-ethynylcyclohexylcarbamate, 95%, 25g

tert-butyl N-[(1S)-1-[4-(4-bromophenyl)-1H-imidazol-2-yl]-2-methylpropyl]carbamate, 1g